A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently inactivated in many forms of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research